↓ Skip to main content

Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer

Overview of attention for article published in BMC Cancer, January 2021
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
20 Mendeley